Vivo Capital VIII, LLC

Insider Reports History

Location
Palo Alto, CA
Signature
Vivo Capital VIII, LLC, By: /s/ Frank Kung, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vivo Capital VIII, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 1,952,302 $1,854,687 $0.9500 21 Nov 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Comon Stock 1,981,474 $1,842,771 $0.9300 17 Nov 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 1,448,286 $1,375,872 $0.9500 21 Nov 2023 By: Vivo Panda Fund, L.P.
IMPEL PHARMACEUTICALS INC 10%+ Owner Common Stock 2,029,495 $588,554 $0.2900 19 Dec 2023 By: Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 269,587 $256,108 $0.9500 21 Nov 2023 By: Vivo Capital Surplus Fund VIII, L.P.
Bolt Biotherapeutics, Inc. 10%+ Owner Common Stock 111,662 $106,079 $0.9500 21 Nov 2023 By: Vivo Opportunity Fund Holdings, L.P.
IMPEL PHARMACEUTICALS INC 10%+ Owner Common Stock 280,294 $81,285 $0.2900 19 Dec 2023 By: Vivo Capital Surplus Fund VIII, L.P.

Insider Reports Filed by Vivo Capital VIII, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMPL IMPEL PHARMACEUTICALS INC 15 Dec 2023 6 -$74,131 4 10%+ Owner 19 Dec 2023, 18:00
BOLT Bolt Biotherapeutics, Inc. 21 Nov 2023 3 -$3,060 4 10%+ Owner 22 Nov 2023, 18:51
BOLT Bolt Biotherapeutics, Inc. 16 Nov 2023 9 -$79,933 4 10%+ Owner 20 Nov 2023, 21:09